1
|
Goals of Care, Critical Care Utilization and Clinical Outcomes in Obese Patients Admitted under General Medicine. J Clin Med 2022; 11:jcm11247267. [PMID: 36555885 PMCID: PMC9786344 DOI: 10.3390/jcm11247267] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/19/2022] [Revised: 12/04/2022] [Accepted: 12/05/2022] [Indexed: 12/13/2022] Open
Abstract
Obesity is associated with long-term morbidity and mortality, but it is unclear if obesity affects goals of care determination and intensive care unit (ICU) resource utilization during hospitalization under a general medicine service. In a cohort of 5113 adult patients admitted under general medicine, 15.3% were obese. Patients with obesity were younger and had a different comorbidity profile than patients who were not obese. In age-adjusted regression analysis, the distribution of goals of care categories for patients with obesity was not different to patients who were not obese (odds ratio for a lower category with more limitations, 0.94; 95% confidence interval [CI]: 0.79-1.12). Patients with obesity were more likely to be directly admitted to ICU from the Emergency Department, require more ICU admissions, and stayed longer in ICU once admitted. Hypercapnic respiratory failure and heart failure were more common in patients with obesity, but they were less likely to receive mechanical ventilation in favor of non-invasive ventilation. The COVID-19 pandemic was associated with 16% higher odds of receiving a lower goals of care category, which was independent of obesity. Overall hospital length of stay was not affected by obesity. Patients with obesity had a crude mortality of 3.8 per 1000 bed-days, and age-adjusted mortality rate ratio of 0.75 (95% CI: 0.49-1.14) compared to patients who were not obese. In conclusion, there was no evidence to suggest biased goals of care determination in patients with obesity despite greater ICU resource utilization.
Collapse
|
2
|
Pouchucq C, Menahem B, Le Roux Y, Bouvier V, Gardy J, Meunier H, Thomas F, Launoy G, Dejardin O, Alves A. Are Geographical Health Accessibility and Socioeconomic Deprivation Associated with Outcomes Following Bariatric Surgery? A Retrospective Study in a High-Volume Referral Bariatric Surgical Center. Obes Surg 2022; 32:1486-1497. [PMID: 35267150 DOI: 10.1007/s11695-022-05937-w] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/22/2020] [Revised: 01/30/2022] [Accepted: 02/03/2022] [Indexed: 11/25/2022]
Abstract
PURPOSE Few studies have evaluated the association between non-clinical determinants (socioeconomic status and geographic accessibility to healthcare) and the outcomes of bariatric surgery, with conflicting results. This study aimed to evaluate this association. METHODS The medical records of 1599 consecutive patients who underwent either laparoscopic Roux-en-Y gastric bypass or laparoscopic sleeve gastrectomy between June 2005 and December 2017 were retrieved. All relevant data, including patient characteristics, biometric values before and after surgery, related medical problems, surgical history, medications, and habitus, for each patient were prospectively collected in a database. Logistic regressions were used to assess the influence of non-clinical determinants on surgical indications and complications. Multilevel linear or logistic regression was used to evaluate the influence of non-clinical determinants on long-term %TWL and the probability to achieve adequate weight loss (defined as a %TWL > 20% at 12 months). RESULTS Analysis of the 1599 medical records revealed that most geographically isolated patients were more likely to have undergone laparoscopic Roux-en-Y gastric bypass (odds ratio: 0.97; 95% confidence interval: 0.94 to 0.99; P = 0.018) and had a greater likelihood of adequate weight loss (β: 0.03; 95% CI: 0.01 to 0.05; P = 0.021). Conversely, socioeconomic status (measured by the European Deprivation Index) did not affect outcomes following bariatric surgery. CONCLUSION Geographical health isolation is associated with a higher probability to achieve adequate weight loss after 1 year of follow-up, while neither health isolation nor socioeconomic deprivation is associated with post-operative mortality and morbidity. This results suggests that bariatric surgery is a safe and effective tool for weight loss despite socioeconomic deprivation.
Collapse
Affiliation(s)
- Camille Pouchucq
- Department of Digestive Surgery, University Hospital of Caen, Avenue de la Côte de Nacre, 14033, Caen Cedex, France.
- UMR INSERM U1086 "ANTICIPE", Centre François Baclesse, Anticipe, France.
- Department of Research, University Hospital of Caen, Caen, France.
| | - Benjamin Menahem
- Department of Digestive Surgery, University Hospital of Caen, Avenue de la Côte de Nacre, 14033, Caen Cedex, France
- UMR INSERM U1086 "ANTICIPE", Centre François Baclesse, Anticipe, France
- Department of Research, University Hospital of Caen, Caen, France
| | - Yannick Le Roux
- Department of Digestive Surgery, University Hospital of Caen, Avenue de la Côte de Nacre, 14033, Caen Cedex, France
| | - Véronique Bouvier
- UMR INSERM U1086 "ANTICIPE", Centre François Baclesse, Anticipe, France
- Department of Research, University Hospital of Caen, Caen, France
| | - Joséphine Gardy
- UMR INSERM U1086 "ANTICIPE", Centre François Baclesse, Anticipe, France
| | - Hugo Meunier
- Department of Digestive Surgery, University Hospital of Caen, Avenue de la Côte de Nacre, 14033, Caen Cedex, France
| | - Flavie Thomas
- Department of Digestive Surgery, University Hospital of Caen, Avenue de la Côte de Nacre, 14033, Caen Cedex, France
- UMR INSERM U1086 "ANTICIPE", Centre François Baclesse, Anticipe, France
- Department of Research, University Hospital of Caen, Caen, France
| | - Guy Launoy
- UMR INSERM U1086 "ANTICIPE", Centre François Baclesse, Anticipe, France
- Department of Research, University Hospital of Caen, Caen, France
| | - Olivier Dejardin
- UMR INSERM U1086 "ANTICIPE", Centre François Baclesse, Anticipe, France
- Department of Research, University Hospital of Caen, Caen, France
| | - Arnaud Alves
- Department of Digestive Surgery, University Hospital of Caen, Avenue de la Côte de Nacre, 14033, Caen Cedex, France
- UMR INSERM U1086 "ANTICIPE", Centre François Baclesse, Anticipe, France
- Department of Research, University Hospital of Caen, Caen, France
| |
Collapse
|
3
|
Feral-Pierssens AL, Matta J, Rives-Lange C, Goldberg M, Zins M, Carette C, Czernichow S. Health care use by adults with obesity: A French cohort study. Obesity (Silver Spring) 2022; 30:733-742. [PMID: 35142072 DOI: 10.1002/oby.23366] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/14/2021] [Revised: 11/21/2021] [Accepted: 11/23/2021] [Indexed: 11/06/2022]
Abstract
OBJECTIVE Studies on obesity costs have focused on global costs of people with obesity but scarcely investigated their precise use of health care. The aim of this study is to document real-life health care use across obesity classes. METHODS Data of participants with obesity and enrolled in the CONSTANCES cohort were analyzed. Health care use was defined as ≥1 visit to general practitioners, specialists, emergency departments, and inpatient hospital admissions versus none over a 3-year period prior to enrollment and was obtained from the Universal Health Insurance database. Multivariate regression models were conducted and adjusted for comorbidities and social deprivation markers with medical visits as the outcome variables and compared people with class II and III obesity versus class I obesity. RESULTS Out of the 10,774 participants with obesity, 613 (5.7%) had class III obesity, and 2,076 (19.3%) had class II obesity. Compared with participants with class I obesity, class III obesity participants had higher odds of visiting emergency departments (OR = 1.31; 95% CI: 1.07-1.61) and various specialist physicians (pneumologists, endocrinologists, cardiologists) but lower odds of visiting gynecologists (OR = 0.69; 95% CI 0.55-0.87). Participants with class II obesity had lower odds of visiting general practitioners, dentists, and psychiatrists. There was no difference with regard to hospital admissions. CONCLUSION Health care use by people with obesity differs across classes.
Collapse
Affiliation(s)
- Anne-Laure Feral-Pierssens
- Population-based Epidemiological Cohorts Unit, INSERM UMS 11, Villejuif, France
- Assistance Publique Hôpitaux de Paris, Emergency Department, Georges Pompidou European Hospital, Paris, France
- IMPEC Federation, Paris, France
| | - Joane Matta
- Population-based Epidemiological Cohorts Unit, INSERM UMS 11, Villejuif, France
| | - Claire Rives-Lange
- Assistance Publique Hôpitaux de Paris, Nutrition Department, Georges Pompidou European Hospital, Centre Spécialisé Obésité, Paris, France
- Université de Paris, Paris, France
- INSERM, UMR 1153 Epidemiology and Biostatistics Sorbonne Paris Cité Center (CRESS), METHODS team, Paris, France
| | - Marcel Goldberg
- Population-based Epidemiological Cohorts Unit, INSERM UMS 11, Villejuif, France
- Université de Paris, Paris, France
| | - Marie Zins
- Population-based Epidemiological Cohorts Unit, INSERM UMS 11, Villejuif, France
- Université de Paris, Paris, France
| | - Claire Carette
- Assistance Publique Hôpitaux de Paris, Nutrition Department, Georges Pompidou European Hospital, Centre Spécialisé Obésité, Paris, France
- Université de Paris, Paris, France
- INSERM, CIC 1418, Georges Pompidou European Hospital, Paris, France
| | - Sébastien Czernichow
- Assistance Publique Hôpitaux de Paris, Nutrition Department, Georges Pompidou European Hospital, Centre Spécialisé Obésité, Paris, France
- Université de Paris, Paris, France
- INSERM, CIC 1418, Georges Pompidou European Hospital, Paris, France
| |
Collapse
|
4
|
Marche JC, Bannay A, Baillot S, Dauriac-Le Masson V, Leveque P, Schmitt C, Laprévote V, Schwan R, Dobre D. Prevalence of severe cardiovascular disease in patients with schizophrenia. Encephale 2021; 48:125-131. [PMID: 34024498 DOI: 10.1016/j.encep.2021.02.008] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/08/2020] [Revised: 02/20/2021] [Accepted: 02/24/2021] [Indexed: 01/09/2023]
Abstract
OBJECTIVES We assessed the prevalence of severe cardiovascular (CV) disease requiring hospitalization among patients with schizophrenia in France. METHOD We included patients hospitalized with schizophrenia or psychotic disorder during 2015, in five French psychiatric hospitals. Patients with CV disease were defined as those with a correspondent ICD-10 code during a hospital stay in any general hospital, five years before or three years after the psychiatric hospitalization. CV disease included myocardial infarction (MI), stroke, heart failure (HF), coronary artery disease (CAD) or peripheral artery disease. Risk factors such as hypertension, obesity and diabetes were recorded. RESULTS In total, 4424 patients with schizophrenia were included. Overall, 203 (4,6%) patients were diagnosed with CV disease, 93 (2.1%) with CAD, 86 (1.9%) with HF and 49 (1.1%) with stroke. The prevalence of hypertension, obesity and diabetes was 11.3%, 9.7% and 7.8%. The median (interquartile range) age of patients with MI and diabetes was 57 (49-70) and 56 (48-66) years. CONCLUSION Patients with schizophrenia develop severe CV disease requiring hospitalization at an early age. These severe events are associated with a high prevalence of risk factors. Early screening and treatment of CV disease and risk factors is important to improve life expectancy and quality of life of these patients.
Collapse
Affiliation(s)
- J-C Marche
- Psychiatry and Clinical Psychology Service (G06), Psychotherapeutic Center of Nancy, 1, rue Dr-Archambault, BP 11010, 54521 Laxou cedex, France; University of Lorraine, Lorraine, France.
| | - A Bannay
- Department of Evaluation and Medical Informatics, CHRU-Nancy, 29, avenue du Maréchal-de-Lattre-de-Tassigny, 54035 Nancy, France
| | - S Baillot
- Department of Evaluation and Medical Informatics, CHRU-Nancy, 29, avenue du Maréchal-de-Lattre-de-Tassigny, 54035 Nancy, France
| | - V Dauriac-Le Masson
- Department of Medical Informatics, GHU Paris "Psychiatrie & Neurosciences", 1, rue Cabanis, 75014 Paris, France
| | - P Leveque
- Department of Medical Informatics, Ravenel Hospital Center, 1115, avenue René-Porterat, 88500 Mirecourt, France
| | - C Schmitt
- Department of Medical Informatics, Jury Hospital Center, centre hospitalier de Jury, BP 75088, 57073 Metz cedex 3, France
| | - V Laprévote
- Grand Nancy Hospital-university Center for Adult Psychiatry and Addictology, Psychotherapeutic Center of Nancy, 1, rue Dr-Archambault, BP 11010, 54521 Laxou cedex, France; University of Lorraine, Lorraine, France; Inserm U1114, France
| | - R Schwan
- Department of Medical Informatics and Clinical Research and Investigation Unit, Psychotherapeutic Center of Nancy, 1, rue Dr-Archambault, 54520 Laxou, France; University of Lorraine, Lorraine, France; Inserm U1254, France
| | - D Dobre
- Department of Medical Informatics and Clinical Research and Investigation Unit, Psychotherapeutic Center of Nancy, 1, rue Dr-Archambault, 54520 Laxou, France
| |
Collapse
|
5
|
Czernichow S, Bain SC, Capehorn M, Bøgelund M, Madsen ME, Yssing C, McMillan AC, Cancino A, Panton UH. Costs of the COVID-19 pandemic associated with obesity in Europe: A health-care cost model. Clin Obes 2021; 11:e12442. [PMID: 33554456 PMCID: PMC7988570 DOI: 10.1111/cob.12442] [Citation(s) in RCA: 19] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/07/2020] [Revised: 12/03/2020] [Accepted: 12/17/2020] [Indexed: 02/06/2023]
Abstract
Excess weight is associated with severe outcomes of coronavirus disease 2019 (COVID-19). We aimed to estimate the total secondary care costs by body mass index (BMI, kg/m2 ) category when hospitalized due to COVID-19 in Europe during the first wave of the pandemic from January to June 2020. Building a health-care cost model, this study aimed to estimate the total costs of COVID-19. Information on risk of hospitalization, admission to intensive care unit (ICU) and risk of ventilation were based on published data. Average cost per patient and in total were calculated based on risks of admission to ICU, risk of invasive mechanical ventilation and length of hospital stay when hospitalized and published costs associated with hospitalization. The total direct costs of secondary care during the first wave of COVID-19 in Europe were estimated at EUR 13.9 billon, whereof 76% accounted for treating people with overweight and obesity. The average cost per hospital admission increased with BMI, from EUR 15831 for BMI <25 kg/m2 to EUR 30982 for BMI ≥40 kg/m2 . This study reveals that excess weight contributes disproportionally to the costs of COVID-19. This might reflect that overweight and obesity caused the COVID-19 pandemic to result in more severe outcomes for citizens and higher secondary care costs throughout Europe.
Collapse
Affiliation(s)
- Sebastien Czernichow
- Service de NutritionUniversité de ParisParisFrance
- Assistance Publique‐Hôpitaux de Paris (AP‐HP)Service de Nutrition, Centre Spécialisé Obésité, Hôpital Européen Georges PompidouParisFrance
- METHODS TeamINSERM, UMR1153, Epidemiology and Biostatistics Sorbonne Paris Cité Centre (CRESS)ParisFrance
| | - Stephen C. Bain
- Diabetes Research UnitSwansea University Medical School and Swansea Bay University Health BoardSwanseaWalesUK
| | - Matthew Capehorn
- Rotherham Institute for Obesity (RIO)Clifton Medical CentreRotherhamSouth YorkshireUK
| | | | | | | | | | | | | |
Collapse
|
6
|
Czernichow S, Beeker N, Rives‐Lange C, Guerot E, Diehl J, Katsahian S, Hulot J, Poghosyan T, Carette C, Jannot A. Obesity Doubles Mortality in Patients Hospitalized for Severe Acute Respiratory Syndrome Coronavirus 2 in Paris Hospitals, France: A Cohort Study on 5,795 Patients. Obesity (Silver Spring) 2020; 28:2282-2289. [PMID: 32815621 PMCID: PMC7461006 DOI: 10.1002/oby.23014] [Citation(s) in RCA: 67] [Impact Index Per Article: 16.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/26/2020] [Revised: 08/07/2020] [Accepted: 08/11/2020] [Indexed: 01/02/2023]
Abstract
OBJECTIVE Preliminary data from different cohorts of small sample size or with short follow-up indicate poorer prognosis in people with obesity compared with other patients. This study aims to precisely describe the strength of association between obesity in patients hospitalized with coronavirus disease 2019 (COVID-19) and mortality and to clarify the risk according to usual cardiometabolic risk factors in a large cohort. METHODS This is a prospective cohort study including 5,795 patients aged 18 to 79 years hospitalized from February 1 to April 30, 2020, in the Paris area, with confirmed infection by severe acute respiratory syndrome coronavirus 2. Adjusted regression models were used to estimate the odds ratios (ORs) and 95% CIs for the mortality rate at 30 days across BMI classes, without and with imputation for missing BMI values. RESULTS Eight hundred ninety-one deaths had occurred at 30 days. Mortality was significantly raised in people with obesity, with the following ORs for BMI of 30 to 35 kg/m2 , 35 to 40 kg/m2 , and >40 kg/m2 : 1.89 (95% CI: 1.45-2.47), 2.79 (95% CI: 1.95-3.97), and 2.55 (95% CI: 1.62-3.95), respectively (18.5-25 kg/m2 was used as the reference class). This increase holds for all age classes. CONCLUSIONS Obesity doubles mortality in patients hospitalized with COVID-19.
Collapse
Affiliation(s)
- Sébastien Czernichow
- Université de ParisParisFrance
- Department of NutritionSpecialized Obesity CenterHôpital Européen Georges PompidouAssistance Publique–Hôpitaux de ParisParisFrance
- Epidemiology and Biostatistics Sorbonne Paris City CenterUMR1153Institut National de la Santé et de la Recherche MédicaleParisFrance
| | - Nathanael Beeker
- Université de ParisParisFrance
- Clinical Research UnitHôpital CochinAssistance Publique–Hôpitaux de ParisParisFrance
| | - Claire Rives‐Lange
- Université de ParisParisFrance
- Department of NutritionSpecialized Obesity CenterHôpital Européen Georges PompidouAssistance Publique–Hôpitaux de ParisParisFrance
- Epidemiology and Biostatistics Sorbonne Paris City CenterUMR1153Institut National de la Santé et de la Recherche MédicaleParisFrance
| | - Emmanuel Guerot
- Université de ParisParisFrance
- Department of Intensive Care MedicineHôpital Européen Georges PompidouAssistance Publique–Hôpitaux de ParisParisFrance
| | - Jean‐Luc Diehl
- Université de ParisParisFrance
- Department of Intensive Care MedicineHôpital Européen Georges PompidouAssistance Publique–Hôpitaux de ParisParisFrance
| | - Sandrine Katsahian
- Université de ParisParisFrance
- Department of Medical Informatics, Biostatistics, and Public HealthHôpital Européen Georges PompidouAssistance Publique–Hôpitaux de ParisParisFrance
- Department of Information Sciences to Support Personalized MedicineCentre de Recherche des Cordeliers, Sorbonne Université, INSERM, Université de ParisParisFrance
| | - Jean‐Sébastien Hulot
- Université de ParisParisFrance
- Clinical Investigation Center 1418Hôpital Européen Georges PompidouAssistance Publique–Hôpitaux de ParisParisFrance
- Cardiovascular, Renal, Transplants, and Neurovascular Medical University DepartmentHôpital Européen Georges PompidouAssistance Publique–Hôpitaux de ParisParisFrance
| | - Tigran Poghosyan
- Université de ParisParisFrance
- Department of Digestive, Oncological, and Bariatric SurgeryHôpital Européen Georges PompidouAssistance Publique–Hôpitaux de ParisParisFrance
| | - Claire Carette
- Université de ParisParisFrance
- Department of NutritionSpecialized Obesity CenterHôpital Européen Georges PompidouAssistance Publique–Hôpitaux de ParisParisFrance
- Clinical Investigation Center 1418Hôpital Européen Georges PompidouAssistance Publique–Hôpitaux de ParisParisFrance
| | - Anne‐Sophie Jannot
- Université de ParisParisFrance
- Department of Medical Informatics, Biostatistics, and Public HealthHôpital Européen Georges PompidouAssistance Publique–Hôpitaux de ParisParisFrance
- Department of Information Sciences to Support Personalized MedicineCentre de Recherche des Cordeliers, Sorbonne Université, INSERM, Université de ParisParisFrance
| | | |
Collapse
|
7
|
Feral-Pierssens AL, Rives-Lange C, Matta J, Rodwin VG, Goldberg M, Juvin P, Zins M, Carette C, Czernichow S. Forgoing health care under universal health insurance: the case of France. Int J Public Health 2020; 65:617-625. [PMID: 32474715 DOI: 10.1007/s00038-020-01395-2] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/18/2019] [Revised: 05/08/2020] [Accepted: 05/19/2020] [Indexed: 11/24/2022] Open
Abstract
OBJECTIVES We investigate the reliability of a survey question on forgone healthcare services for financial reasons, based on analysis of actual healthcare use over the 3-year period preceding response to the question. We compare the actual use of different health services by patients who report having forgone health care to those who do not. METHODS Based on a prospective cohort study (CONSTANCES), we link survey data from enrolled participants to the Universal Health Insurance (UHI) claims database and compare use of health services of those who report having forgone health care to controls. We present multivariable logistic regression models and assess the odds of using different health services. RESULTS Compared to controls, forgoing care participants had lower odds of consulting GPs (OR = 0.83; 95% CI 0.73, 0.93), especially specialists outside hospitals (gynecologists: 0.74 (0.69, 0.78); dermatologists: 0.81 (0.78-0.85); pneumologists 0.82 (0.71-0.94); dentists 0.71 (0.68, 0.75)); higher odds of ED visits (OR = 1.25; 95% CI 1.19, 1.31); and no difference in hospital admissions (OR = 1.02; 95% CI 0.97, 1.09). Participants with lower occupational status and income had higher odds of forgoing health care. CONCLUSIONS The perception of those who report having forgone health care for financial reasons is consistent with their lower actual use of community-based ambulatory care (CBAC). While UHI may be necessary to improve healthcare access, it does not address the social factors associated with the population forgoing health care for financial reasons.
Collapse
Affiliation(s)
- Anne-Laure Feral-Pierssens
- Population-Based Epidemiological Cohorts Unit, INSERM UMS 11, Villejuif, France. .,Assistance Publique Hôpitaux de Paris, Emergency Department, Georges Pompidou European Hospital, Paris, France. .,Improving Emergency Care - IMPEC federation, Paris, France.
| | - Claire Rives-Lange
- Assistance Publique Hôpitaux de Paris, Nutrition Department, Georges Pompidou European Hospital, Centre Spécialisé Obésité, Paris, France.,Paris University, Paris, France.,INSERM, UMR 1153 Epidemiology and Biostatistics Sorbonne Paris Cité Center (CRESS), METHODS Team, Paris, France
| | - Joane Matta
- Population-Based Epidemiological Cohorts Unit, INSERM UMS 11, Villejuif, France
| | - Victor G Rodwin
- Département Epidémiologie et Systèmes de Santé, UniSanté, Lausanne, Switzerland.,Wagner School of Public Service, New York University, New York, USA
| | - Marcel Goldberg
- Population-Based Epidemiological Cohorts Unit, INSERM UMS 11, Villejuif, France.,Paris University, Paris, France
| | - Philippe Juvin
- Assistance Publique Hôpitaux de Paris, Emergency Department, Georges Pompidou European Hospital, Paris, France.,Improving Emergency Care - IMPEC federation, Paris, France.,Paris University, Paris, France
| | - Marie Zins
- Population-Based Epidemiological Cohorts Unit, INSERM UMS 11, Villejuif, France.,Paris University, Paris, France
| | - Claire Carette
- Assistance Publique Hôpitaux de Paris, Nutrition Department, Georges Pompidou European Hospital, Centre Spécialisé Obésité, Paris, France.,CIC1418, INSERM, Georges Pompidou European Hospital, Paris, France
| | - Sebastien Czernichow
- Assistance Publique Hôpitaux de Paris, Nutrition Department, Georges Pompidou European Hospital, Centre Spécialisé Obésité, Paris, France.,Paris University, Paris, France.,INSERM, UMR 1153 Epidemiology and Biostatistics Sorbonne Paris Cité Center (CRESS), METHODS Team, Paris, France
| |
Collapse
|
8
|
Scailteux LM, Droitcourt C, Balusson F, Nowak E, Kerbrat S, Dupuy A, Drezen E, Happe A, Oger E. French administrative health care database (SNDS): The value of its enrichment. Therapie 2019; 74:215-223. [DOI: 10.1016/j.therap.2018.09.072] [Citation(s) in RCA: 27] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/27/2018] [Accepted: 09/07/2018] [Indexed: 01/15/2023]
|
9
|
Demotes-Mainard J, Cornu C, Guérin A, Bertoye PH, Boidin R, Bureau S, Chrétien JM, Delval C, Deplanque D, Dubray C, Duchossoy L, Edel V, Fouret C, Galaup A, Lesaulnier F, Matei M, Naudet F, Plattner V, Rubio M, Ruiz F, Sénéchal-Cohen S, Simon T, Vidal A, Viola A, Violleau M. Quel impact du nouveau règlement européen sur la protection des données sur la recherche clinique et recommandations. Therapie 2019; 74:17-29. [DOI: 10.1016/j.therap.2018.11.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/09/2018] [Accepted: 11/13/2018] [Indexed: 11/26/2022]
|
10
|
Demotes-Mainard J, Cornu C, Guérin A, Bertoye PH, Boidin R, Bureau S, Chrétien JM, Delval C, Deplanque D, Dubray C, Duchossoy L, Edel V, Fouret C, Galaup A, Lesaulnier F, Matei M, Naudet F, Plattner V, Rubio M, Ruiz F, Sénéchal-Cohen S, Simon T, Vidal A, Viola A, Violleau M. How the new European data protection regulation affects clinical research and recommendations? Therapie 2019; 74:31-42. [DOI: 10.1016/j.therap.2018.12.004] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/25/2018] [Accepted: 11/05/2018] [Indexed: 11/27/2022]
|